Publication | Closed Access
MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma
33
Citations
21
References
2019
Year
Neuro-oncologyOncologyGliomaTemozolomide ResistanceMedicinePathologyCancer Cell BiologyCancer GenomicsPoor PrognosisHigh-grade GliomasCancer TreatmentCancer GeneticsMpc1 DeletionCancer BiologyCell BiologyTumor SuppressorTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1